Search

Your search keyword '"Ontwikkelingsstoornissen Med."' showing total 86 results

Search Constraints

Start Over You searched for: Author "Ontwikkelingsstoornissen Med." Remove constraint Author: "Ontwikkelingsstoornissen Med."
86 results on '"Ontwikkelingsstoornissen Med."'

Search Results

1. Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts

2. Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial

3. Erratum: Evaluating changes in functioning and psychological distress in visitors of the @ease youth mental health walk-in centres (BJPsych Open (2024) 10:3 (e101) DOI: 10.1192/bjo.2024.58)

4. Polygenetic risk scores and phenotypic constellations of obsessive–compulsive disorder in clozapine-treated schizophrenia

5. The ethics of polygenic scores in psychiatry: minefield or opportunity for patient-centered psychiatry?

7. Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder

9. An international research agenda for clozapine-resistant schizophrenia

10. The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder

11. Op naar een gepersonaliseerde clozapinebehandeling

12. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia

16. Leerdoelen over kinder- en jeugdpsychiatrie in de opleiding psychiatrie: een delphistudie

17. Lifestyle interventions for people with a severe mental illness living in supported housing: A systematic review and meta-analysis

18. Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe

20. Psychiatrie en genetica: de lange weg van laboratorium naar spreekkamer

21. Information extraction from free text for aiding transdiagnostic psychiatry: constructing NLP pipelines tailored to clinicians’ needs

22. Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders

23. A normative chart for cognitive development in a genetically selected population

24. Within-family influences on dimensional neurobehavioral traits in a high-risk genetic model

25. A global perspective on training and education in child and adolescent psychiatry

30. UNTARGETED METABOLIC PROFILING IN DRIED BLOOD SPOTS REVEALS METABOLIC FINGERPRINT FOR 22Q11.2 DELETION SYNDROME

31. Transcriptomic profiling of whole blood in 22q11.2 reciprocal copy number variants reveals that cell proportion highly impacts gene expression

32. Impact of the first COVID-19 outbreak on mental health service utilisation at a Dutch mental health centre: Retrospective observational study

33. Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith–Magenis syndrome: protocol for a series of N-of-1 trials

34. Psychiatric phenotypes associated with hyperprolinemia: A systematic review

37. Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial

38. Glasgow Antipsychotica Bijwerkingen Schaal voor Clozapine; validatie van de Nederlandstalige versie

40. Neutrophil fluorescence in clozapine users is attributable to a 14kDa secretable protein

41. Beloop van covid-19-infecties en impact op mentale gezondheid; opzet van een landelijk casusregister

43. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study

44. Psychose en bewegingsstoornissen bij een adolescent met 22q11.2-deletiesyndroom

48. Slow segmentation of faces in Autism Spectrum Disorder

49. Brain Responses to Faces and Facial Expressions in 5-Month-Olds: An fNIRS Study

50. Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior

Catalog

Books, media, physical & digital resources